A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis: Effectiveness on White Blood Cell Cystine Levels and Comparison of Safety

BACKGROUND AND OBJECTIVES: Immediate-release cysteamine bitartrate (Cystagon; Mylan Pharmaceuticals, Canonsburg, PA) may prevent or delay kidney transplantation and other serious outcomes in patients with cystinosis, but has never been subjected to a prospective clinical trial. Cystagon efficacy req...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langman, Craig B., Greenbaum, Larry A., Sarwal, Minnie, Grimm, Paul, Niaudet, Patrick, Deschênes, Georges, Cornelissen, Elisabeth, Morin, Denis, Cochat, Pierre, Matossian, Debora, Gaillard, Segolene, Bagger, Mary Jo, Rioux, Patrice
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3386675/
https://ncbi.nlm.nih.gov/pubmed/22554716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12321211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados